PT  - JOURNAL ARTICLE
AU  - Kono, Helena Noéline
AU  - Ada Mengome, Mérédith Flore
AU  - Pongui Ngondza, Bedrich
AU  - Sibi Matotou, Roger Hadry
AU  - Ndong Akomezoghe, Luccheri
AU  - Ekomi, Bernadette
AU  - Moutombi Ditombi, Bridy Chesly
AU  - Koumba Lengongo, Jeanne Vanessa
AU  - Ndong Ngomo, Jacques Mari
AU  - M’Bondoukwé, Noé Patrick
AU  - Bisseye, Cyrille
AU  - Mawili-Mboumba, Denise Patricia
AU  - Bouyou Akotet, Marielle Karine
TI  - C-reactive protein and high-sensitivity C-reactive protein levels in asymptomatic intestinal parasite carriers from urban and rural areas of Gabon
AID  - 10.1101/2023.04.08.23288297
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.04.08.23288297
4099  - http://medrxiv.org/content/early/2023/04/09/2023.04.08.23288297.short
4100  - http://medrxiv.org/content/early/2023/04/09/2023.04.08.23288297.full
AB  - Background Chronic carriage of intestinal parasitic infections (IPIs) can induce chronic inflammation and dysbiosis, which are risk factors for non-communicable diseases. The objective of this study was to determine the relationship between IPI carriage and inflammation in a population of volunteers living in Gabon.Methodology and Principal Findings A cross-sectional study was conducted from September 2020 to November 2021 in asymptomatic participants aged 18 years and over residing in different areas of Gabon: Libreville (urban area) and Koula-Moutou and Bitam (rural areas). The detection of IPIs was carried out using common techniques. Inflammation markers, C-reactive protein (CRP), and high-sensitivity C-reactive protein (hsCRP) were assayed. Overall, 518 participants were included, 64.5% (n = 334) of whom resided in urban area and 35.5% (n = 184) in rural areas. The median age was 35 years [27; 46]. The prevalence of asymptomatic IPIs was 29.9% (n = 155), with a significantly higher frequency in rural areas than in urban area (adjusted OR 6.6 [CI 3.2-13.8], p < 0.01). Protozoa were more frequent than soil-transmitted helminths (STHs) in both areas: 81.6% (n = 40) in urban area and 69.8% (n = 74) in rural areas. STHs were predominant in rural areas (48.1%) than in urban area (22.4%). High concentrations of hsCRP and CRP were significantly more frequent in inhabitants of rural areas (23.4% (n = 43) and 56.5% (n = 104), respectively (p < 0.01) than those of urban area (11.1% (n = 37) and 34.5% (n = 116), respectively; p<0.01). High levels were more frequent in parasitized individuals (for hsCRP, 22.6%, n = 35, p < 0.01, for CRP, 52.9%, n = 82; p < 0.01); in particular among STH carriers (for hsCRP; 65.9%, n = 27, p < 0.01, for CRP: 36.6%, n = 15; p < 0.01).Conclusions/Significance This first study showed that asymptomatic IPIs, especially STHs, are associated with higher CRP and hsCRP levels. Others biomarkers of inflammation must be analyzed to confirm the relationship between asymptomatic IPIs and chronic inflammation.Author summary Repeated or chronic parasitism can maintain local or systemic chronic inflammation, CRP and hsCRP are sensitive biomarkers of subclinical low-grade inflammation. This study assessed the serum levels of CRP and hsCRP in adults with or without intestinal parasite (IPI) carriage according to residence area and parasite species. IPI chronic carriage, especially with pathogenic protozoa and/or STH, was associated with higher levels of CRP and hsCRP. These findings suggest that intestinal parasite carriage contributes to low grade systemic inflammation which is a driver of NCD. The role of chronic carriage of other enteropathogens on chronic inflammation status as well the relationship between IPI and dysbiosis should be further analyzed in endemic countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by EDCTP2 programAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The National Ethics Committee of Gabon of Full Institution name gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the study are available upon reasonable request from the authors